These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20829130)

  • 1. Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates.
    Sparidans RW; Iusuf D; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2751-9. PubMed ID: 20829130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma.
    Sparidans RW; Iusuf D; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(32):4090-6. PubMed ID: 19910267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite.
    Sparidans RW; Vlaming ML; Lagas JS; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):269-76. PubMed ID: 19117812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma.
    Sparidans RW; Durmus S; Xu N; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():174-7. PubMed ID: 22476054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver, brain and small intestinal contents and in OptiMEM cell culture medium.
    Sparidans RW; Lagas JS; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):200-10. PubMed ID: 17544343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-tandem mass spectrometric assay for the ALK inhibitor crizotinib in mouse plasma.
    Sparidans RW; Tang SC; Nguyen LN; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():150-4. PubMed ID: 22940474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography-tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasma.
    Sparidans RW; Prins JM; Schellens JH; Beijnen JH
    Biomed Chromatogr; 2007 Jun; 21(6):621-7. PubMed ID: 17340566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma.
    Sparidans RW; Lagas JS; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):77-82. PubMed ID: 18674973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the tyrosine kinase inhibitor pazopanib in human plasma.
    Sparidans RW; Ahmed TT; Muilwijk EW; Welzen ME; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():137-40. PubMed ID: 22917595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography-tandem mass spectrometric assay for the VEGFR inhibitor cediranib and its primary human metabolite cediranib-N⁺-glucuronide in plasma.
    Sparidans RW; Durmus S; Xu N; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():169-73. PubMed ID: 22476055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis.
    Sparidans RW; van Velsen SG; de Roos MP; Schellens JH; Bruijnzeel-Koomen CA; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2150-4. PubMed ID: 20605116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
    Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
    J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma.
    Sparidans RW; Martens I; Valkenburg-van Iersel LB; den Hartigh J; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1851-6. PubMed ID: 21622034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor dabrafenib in mouse plasma.
    Sparidans RW; Durmus S; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():124-8. PubMed ID: 23537694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor vemurafenib in human and mouse plasma.
    Sparidans RW; Durmus S; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():144-7. PubMed ID: 22386128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of pravastatin acid, lactone and isomers in human plasma by UHPLC-MS/MS and its application to a pediatric pharmacokinetic study.
    van Haandel L; Gibson KT; Leeder JS; Wagner JB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():169-77. PubMed ID: 26849185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis.
    Bourget P; Amin A; Chandesris MO; Vidal F; Merlette C; Hirsch I; Cabaret L; Carvalhosa A; Mogenet A; Frenzel L; Damaj G; Lortholary O; Hermine O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():175-81. PubMed ID: 24316764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma.
    Luethi D; Durmus S; Schinkel AH; Schellens JH; Beijnen JH; Sparidans RW
    Biomed Chromatogr; 2014 Oct; 28(10):1366-70. PubMed ID: 24619951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates.
    Sparidans RW; Li W; Schinkel AH; Schellens JHM; Beijnen JH
    J Pharm Biomed Anal; 2018 Nov; 161():136-143. PubMed ID: 30149189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of spinosin in rat plasma by liquid chromatography-tandem mass spectrometry method.
    Li Y; Yao M; Cheng S
    J Pharm Biomed Anal; 2008 Dec; 48(4):1169-73. PubMed ID: 18834689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.